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Mast cell secretion of the chemical mediators of immediate hypersensitivity such as 
histamine is generally initiated in vivo by antigen interaction with IgE antibodies on 
the mast  cell surface  (1-4).  Mast  cell degranulation also  may be  initiated by the 
anaphylatoxins C3a  and  C5a  generated by complement  activation  (5,  6)  and  by 
cationic polypeptides from polymorphonuclear leukocyte granules (7, 8). Nonphysio- 
logic stimuli of mast cell mediator release without generalized cytotoxic effects include 
compound 48/80  (9,  10), polymyxin B (11,  12), the calcium ionophore A-23187  (10, 
13), and the hypoxanthine-xanthine oxidase system (14). 
Eosinophils are often closely associated with mast cells in tissues, particularly in 
areas of immediate hypersensitivity. Activation of eosinophils can induce the release 
of their granule components into the phagocytic vacuole (1.5-17) or extracellular fluid 
(18-21).  Among these  is the eosinophil peroxidase  (EPO) t which is present  in  the 
eosinophil granule matrix in high concentration (22). The substrate for this enzyme, 
H202, is also generated by activated eosinophils (23-25).  EPO,  like the neutrophil 
peroxidase  (myeloperoxidase [MPO]),  forms a  microbicidal  (26-28)  and  cytotoxic 
(29) system when combined with H202 and a halide. EPO, which is a strongly basic 
protein, also binds firmly to the matrix of isolated mast cell granules (MCG)  with 
retention of peroxidatic activity; indeed, the MCG/EPO complex is more effective 
than free EPO as the catalyst of the peroxidase-mediated antimicrobial system (30). 
These findings prompted a study of the effect of the EPO-HaO2-halide system on 
mast cells. The following dual effect was found: at relatively low EPO concentrations 
specific secretion occurs, whereas when the EPO concentration is raised, lysis of the 
mast cells results  in  the release of all cytoplasmic components.  EPO  binds  to  the 
released MCG to form a  complex with retention, indeed potentiation, of secretory 
activity on mast cells. 
Materials and Methods 
Speaal  Reagents  Guaiacol  (anhydrous),  fl-nicotinaminde  adenme  dinucleotide,  reduced 
form (fl-NADH), pyruvic acid (sodium salt, type II), lactate dehydrogenase  (LDH), o-phthal- 
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dialdehyde (OPT), human albumin (essentially fatty acid-free), and histamine d,phosphate 
were obtained from Sigma Chemical Co.  (St  Louis, Mo.), ligroine from Eastman Kodak Co 
(Rochester,  N  Y.),  glutaraldehyde and uranyl acetate from Polysciences,  Inc  (Warrmgton, 
Pa ), osmium tetroxlde (OsO4), Epon 812, and 3,3-diaminobenztdine  tetrahydrochloride (DAB) 
from Scientific Chemical Co. (Huntington Beach, Calif.), and sodmm heparin (beef lung) from 
Up.lohn Co.,  Agricultural Prods MKT  (Kalamazoo, Mich.)  All other reagents were of the 
highest commercial grade available 
Peroxzdase Preparations EPO was partially purified from gumea pig peritoneal eosinophils by 
gel filtration on Bio-Gel P-150 (Bio-Rad Laboratories, Richmond, Calif) as previously described 
(28)  MPO was prepared in highly purified form from canine pyometral pus by the method of 
Agner to  the end of step  6  (31). EPO and MPO were  heated  at  100°C for  15  mm where 
indicated. The peroxldase activities of EPO and MPO were determined by gualacol oxidauon 
(32)  1 U of enzyme is the amount which oxidizes  1 #mol of electron donor/min at 25°C  A 
molar absorbancy of 2.66 ×  105 M -1 cm  -~ at 470 nm was employed (33). All spectrophotometric 
analyses were performed using a Cary M-15 spectrophotometer (Cary Instruments, Monrovia, 
Cahf.). 
Isolation of Mast Cells. Peritoneal cells were obtained from 200-g male Sprague-Dawley rats by 
lavage with Tyrode's buffer containing 10 U/ml heparin. The cell suspension which contained 
4-5%  mast  cells  was  layered on  38%  bovine serum albumin, and  the  mast  cell-rich pellet 
collected by centrifugation. The cell  suspension, washed  and suspended m  Tyrode's buffer 
contained >90% mast cells with < 10% mononuclear cells and < 1% eosinophils as determmed 
by toluidine blue staining (34). The mast cells were always greater than 95% viable as assessed 
by trypan blue dye exclusion (35). 
Preparatzon of MCG/EPO Complexes. MCG free of perigranular membranes were obtained by 
osmotic lysis of purified mast cells followed by differential centrifugation (36) The MCG were 
washed twice m 0.1 M phosphate buffer, pH 7 0, to remove histamine and other loosely bound 
mediators (36) For preparation of MCG/EPO complexes, EPO was incubated with histamine- 
free MCG m 0.1  M  phosphate buffer, pH  7 0 for 30 min at 37°C (30) The complexes were 
washed three times and suspended in water 
Measurement of Histamine Release. Mast cells were preincubated for 5 mm at 37°C in a water 
bath oscillating 80 times/ram  The components of the reaction mixture (see legends to Figures 
and Tables) were added to a total volume of 0 5 ml with the MPO or EPO added last to start 
the reaction  Unless otherwise indicated, incubations were for 5 mm at 37°C after which the 
suspensions were placed on ice untd centnfugation at 400 g for 6 mm at 4°C  The histamine 
content of the supernatant fraction and pellet was determined fluorometrically using OPT (37) 
Fluorometnc readings were made between 360  and 480 nm using a  model  110 fluorometer 
(Turner Associates, Div  of American Sterilizer Co., Palo Alto, Calif.)  The percent histamine 
release  was calculated as follows:  (supernatant histamine/pellet plus supernatant histamine) 
×  100. 
Measurement of LDH  Release.  Incubauon of mast  cells,  termmauon of the  reaction,  and 
centrifugat,on were performed as described under measurement of histamine release.  The cell 
pellets were suspended in 0.05  M  phosphate buffer, pH  7.5, freeze-thawed three times, and 
centrifuged at  2,000 g  The LDH  activity of this supernate was  determined by the  fall  m 
absorbance at  340 nm on incubation of the cell  preparations with sodium pyruvate and ~- 
NADH m phosphate buffer, pH 7 5 (38) The LDH acuvlty of control cells incubated m buffer 
alone was  determined following comparable treatment, and  the  percent  LDH  release  was 
calculated as follows: (control -  experimental LDH/control LDH) ×  100 
Histamine Degradation by the Peroxtdase Systems. Histamine was incubated with the components 
of the peroxidase system as described in the legend to Table III, and the histamine level was 
determined fluorometncally as described above 
Electron Mzcroscoptc Stu&es  Pellets of 2 ×  106 mast cells incubated with the various components 
of the reaction mixture (see legends to Figures)  were collected by centrifugation at 400 g, fixed 
m 2% glutaraldehyde, postfixed  with  1% OsO4, stained w,th 0 5% uranyl acetate, dehydrated 
with ethanol, and embedded in EPON 812  Some pellets were treated with a saturated solutmn 
of 3,3-diaminobenzidine  and 0 015% H202 for detecuon of peroxidase (39) after a brief period 
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with a JEOL 100B electron microscope (Japan Electron Optics Laboratory, Tokyo, Japan) at 
60 kV 
Statzstzcal Analysts.  The data are reported as the mean ±  SE of the combined experiments. 
Differences  were analyzed for significance  using Student's two-tailed t test  for independent 
means except in Table IV where paired analysis was used (not significant,  P <  0.05) 
Results 
Degranulatzon.  Greater than  95% of the  mast cells incubated  in  buffer alone for 5 
min  at  37°C  exhibited  the  usual  morphology  of  unstimulated  cells  (Fig.  1  A). 
Unstimulated  mast  cells  are  distinguished  from  other  cells  by  the  presence  of a 
number of electron-dense, membrane-bound, cytoplasmic granules. Other cytoplasmic 
organelles (e.g., mitochondria, endoplasmic reticulum, Golgi vesicles) are not unusual, 
and  the  cell  is  surrounded  by  a  plasma  membrane  with  numerous  membrane 
projections. Less than 5% of control cells showed evidence ofdegranulation ultrastruc- 
turally. 
In  contrast,  40-60%  of the  mast  cells  incubated  with  EPO  (25-30  mU),  H~O2 
(2  ×  10  -s  M),  and  iodide  (10  -4  M)  had  uhrastructural  changes  characteristic  of 
degranulation (Fig. 1 C). Many granules were swollen and less electron dense; vacuole- 
like structures containing two or more granules formed, and the altered granules were 
extruded into the extraceUular fluid. There was no evidence of cytotoxic damage at 
this low level of EPO. When any of the components of the EPO-H202-iodide system 
were omitted, mast cell ultrastructure was indistinguishable from that of control cells. 
A mast cell following incubation with H202 and iodide (i.e., EPO deletion)  is shown 
in Fig.  1 B. 
Noncytotoxic degranulation of mast cells by EPO, H2Oz and iodide was confirmed 
by measurement of histamine  and  LDH release  (Table I).  Mast  cells incubated  in 
Tyrode's buffer alone for 5  min spontaneously released  7.2%  of the granule marker 
histamine  and  4.5%  of the  cytoplasmic  marker  LDH  into  the  extracellular  fluid 
(Table I). The further addition  of compound  48/80  (1  #g/ml)  increased  histamine 
release  to  59.3%  without  affecting  LDH  release,  an  effect  expected  for  this  agent 
which  initiates  mast  cell  degranulation.  A  comparable  effect  was  observed  when 
compound 48/80 was replaced by EPO (25-30 mU), H2Oa (2 ×  10  -6 M), and iodide 
(10  -4 M);  histamine release was increased to 53.2%, whereas LDH release remained 
at 4.9%.  Histamine release was abolished by omission of any of the components of the 
EPO-H202-iodide  system, by heat  inactivation  of EPO, and by the addition  of the 
hemeprotein inhibitors azide, cyanide, and aminotriazole. The hemeprotein inhibitors, 
at the same concentrations, did not affect histamine release induced by 1 ~g/ml 48/ 
80  (data not  shown).  MPO when combined with  the same concentrations  of H202 
and  iodide  also  induced  noncytotoxic  mast  cell  degranulation.  As  with  the  EPO 
system,  omission  of components,  heat  inactivation  of MPO,  and  addition  of the 
inhibitors azide  (10  -a M), cyanide (10  -a M), and aminotriazole  (10  -2 M)  prevented 
histamine release (data not shown). 
In Table I, chloride at 0.14 M  was present in the reaction mixture as a component 
of the Tyrode's buffer. That chloride alone could  not  meet  the halide  requirement 
under these conditions was indicated  by the loss of histamine release on deletion  of 
iodide from the complete peroxidase system. However, when the pH of the Tyrode's 
buffer was lowered  (by omission of bicarbonate and addition  of HCI) to 6.5 or 6.0, 
histamine release in the absence of iodide was observed (Fig.  2), presumably caused 268  EOSINOPHIL  PEROXIDASE-INDUCED  MAST  CELL  SECRETION 
FIG  1  Rat mast cells incubated m  Tyrode's buffer, pH  7 4, alone (A, X 6,000) or supplemented 
as described in Table I with H~D~ and iodide  (B,  x  5,600)  or with EPO,  H202 and iodide  (C,  x 
9,500)  The cell seen in  (B)  (EPO deleuon) is indistinguishable from the control cell  (A)  In both, 
the cytoplasm contains fully developed, electron-dense, homogeneous granules with no evidence of 
granule secretion.  The  nucleus, Golgi  vesicles, and  other  organelies appear  normal  and  typical 
mlcrorldges extend from the cell surface  The cell in (C) exhibits ultrastructural features character- 
Istlc  of mast  cell  secretion.  Many  swollen  and  less dense  granules  (G)  are  seen  m  vacuoles or 
channels, some of which open to the outside ofthe cell (arrows)  Other granules and the mtergranular 
cytoplasm, nucleus, mltochondrla, Golgl vetscles, and plasma membrane appear unaffected 60- 
HENDERSON,  E  Y  CHI,  AND  S.  J  KLEBANOFF 
TABLE  I 
EPO/ HeO2/  I--mduced Histamine Release * 
269 
Supplements  Histamine release  LDH release 
'7~  '7, 
Mast cells (spontaneous release)  7.2 4- 1.0 (8):1:  4 5 4- t 2 (8) 
Mast cells plus 48/80  59 3 4- 5  1 (5)  <0.001  3.7 4-  1.4 (5) 
Mast  cells  plus  EPO  plus  H202  53 2 4- 4 8 (5)  <0.001  4.9 4- 1.5 (5) 
plus Iodide 
H202 omitted  9 9 4- 0 7 (5)  2 8 ±  0 9 (5) 
Iodide omitted  11 9 4- 2 0  (7)  3.1  ±  1 1 (7) 
EPO omttted  10.5 4- 0.8 (8)  3.5 4- 0 8  (8) 
EPO heated  7 9 ±  1.6 (4)  4 8 4-  1.5 (4) 
Azlde (10  -3 M) added  10.l 4- 2.1  (3)  3.0 4- 1.9 (3) 
Azlde (10  -4 M) added  11 6 ±  0.9 (3)  2 3 4-  1 5  (3) 
Azide (10  -5 M) added  54 6 4- 6.3 (3)  <0.001  4.7 4- 2 l  (3) 
Cyamde (10  -z M) added  10 5 ±  4  1 (3)  5 3 4- 3 1 (3) 
Cyanide (10  -4 M) added  58.3 4- 6.8 (3)  <0001  4.5 4- 2.1  (3) 
Aminotriazole (10  -2 M) added  10 6 4- 3.1  (3)  3.5 ±  1.7 (3) 
Aminotnazole (10  -3 M) added  17.1 4- 6.1 (3)  2.1  -4- 0 9 (3) 
Ammotnazole (10  -4 M) added  59 5 ±  7 1 (3)  <0 001  3 3 4-  1 4  (3) 
Mast  cells plus  MPO  plus  HzO2  38 1 4- 3 5 (5)  <0.001  4 7 4-  1 9 (5) 
plus todide 
* The reaction m~xture contained 2 x  l0  s mast cells in Tyrode's buffer, pH  7 4  and where 
indicated,  1 #g/ml compound 48/80, 25-30 mU EPO or MPO, 2 x  10  -5 M  H2Oz,  10  -4 M 
Nal  and  azide, cyanide, and aminomazote at  the concentrations indicated  Probabdlty 
values for the difference from the mast cells alone (spontaneous release) are shown where 
sLgmficant (P <  0 05) 
:]: Mean +  SE of (n) experiments 
50- 
40- 
30- 
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FXG  2.  Effect of pH on histamine release by the EPO (MPO)-HzO2-chloride system. The reaction 
mixture contained 2 5 ×  105 mast cells, 25-30 mU EPO (O)  or MPO (C)), and 2 ×  10  -5 M  H202 m 
Tyrode's buffer at the pH indicated  The pH of the buffer was vaned by deleuon of NaHCO3 and 
adjustment with 6 N  HCI. Histamine release above background (mean 4- SE of four experiments) 
is shown. The background was 7.6 4- 1.8% at pH 7.4, 9.6 4- 2.8% at pH 6.5; and 13.7 4- 3.4% at pH 
6 0, and LDH release was <5 0% at each data point 270  EOSINOPHIL PEROXIDASE-INDUCED MAST CELl, SECRETION 
by the presence of chloride in  the  reaction mixture.  MPO  also was  effective under 
these conditions, although the histamine release induced by the EPO-mediated system 
was  greater than  that  induced by the MPO  system at  equivalent  guaiacol units  of 
peroxidase activity. In Table II, Tyrode's buffer was  replaced by phosphate  buffer, 
pH  7.4,  containing  CaSO4.  Background  histamine  release  was  higher  under  these 
conditions; however, the further addition of EPO,  H202,  and  iodide at  10 -4 or  10  -5 
M  significantly  increased  release  Iodide  at  10 -6  M  and  chloride  at  0.1  M  were 
ineffective individually; however, when combined, they could meet the halide require- 
ment  of  the  peroxidase  system  The  choride-free  phosphate  buffer  could  not  be 
employed  at  pH  6.5  or  6.0  because  spontaneous  histamine  release  increased  to 
unacceptable levels (>20%)  under these conditions. 
It has been  reported that  histamine  Is deaminated by MPO  when  supplemented 
with H202  (4 X  10 -3 M) and chloride (0.124 M) at pH 5.3, but not at pH 7.0 (40). In 
this  study,  iodide could  not  substitute  for chloride in  the  MPO-dependent  system, 
and  EPO  at  both  pH  levels had  no  activity with  either halide (40).  These  findings 
raised  the  possibility  that  our  results  may  be  influenced  by  the  degradation  of 
histamine  by  the  peroxidase systems.  As seen  in  Table  III,  however,  there  was  no 
degradation  of histamine  under  the conditions employed here  (pH  7.4;  H202,  2  × 
10  -~ M;  EPO  or MPO,  25-30  mU;  iodide,  10 -4 M;  chloride, 0.14  M)  as measured 
fluorometrically. The  results were comparable at  pH  5.3.  We confirmed  the degra- 
dation of histamine  at  the  higher  H202  concentration  (4  X  10 -a  M)  employed  by 
Fabian and Aronson  (40).  However, under our conditions, H202  alone significantly 
decreased histamine levels at pH 5.3, and the further addition of MPO  and chloride 
increased the degradation seen with H202 at both pH 5.3 and  7.4  (data not shown). 
EPO binds to isolated MCG to form a complex which retains the capacity to induce 
mast  cell  degranulation  when  supplemented  with  H202  and  iodide  (Table  IV). 
Indeed,  the  MCG/EPO  complex-H202-iodide  system  produced  greater  histamine 
release than the comparable granule-free EPO system when standardized to the same 
guaiacol units of peroxidase activity. When the MCG/EPO  complexes were incubated 
TABLE II 
Effect of Hahde  Concentratwn * 
Supplements  Histamine release 
None  l0 2 + 3 4:~ 
EPO plus H202 plus Iodide (10  -4 M)  44 5 ± 4 9  <0 002 
EPO plus HeO2 plus Iodide (10  -~ M)  36 2 ± 3 6  <0 002 
EPO plus H202 plus iodide (10  -6 M)  9 6 +  1 9 
EPO plus H202 plus chloride (10  -I M)  8 9 ± 3 8 
EPO plus H202 plus Iodide (10-6 M) plus  273±40  <002 
chloride (10  -I M) 
* The reaction mmture was as described for the mast cells plus EPO plus H202 
plus todtde system m Table I except that the Tyrode's buffer was replaced 
bv 0 1 M sodmm phosphate buffer, pH 7 4, containing 0 7 mM CaSO4, and 
the hahde was varied as mdmated  Probablhty values for the dtfference from 
the mast cells alone (spontaneous release) are shown where sigmficant (P < 
0 05) 
:~ Mean + SE of four experiments W  R  HENDERSON,  E  Y  CHI,  AND S. J.  KLEBANOFF 
T^m.E  III 
Peroxtdation of Histamine* 
Supplements 
Histamine 
pH 5 3  pH 74 
#g 
None  4.3 +  0.2:[:  4 2 ±  0 2 
H~O2  4 6  ±  0 3  4.4 ±  0 2 
H~O~ plus EPO plus iodide  4.4 ± 0.2  4 2 ± 0 1 
H202 plus EPO plus chloride  4 5 ±  0 2  4 2 ±  0 3 
H202 plus MPO plus iodide  4 5 :t: 0.2  4 4 ± 0 2 
H202 plus MPO plus chloride  4.3 ± 0.4  4 3 ±  0.5 
* The reacuon mixture contained 4 pg histamine in 0.1 M phosphate buffer at 
pH 5.3 or 7 4, and where indicated, 2 ×  l0  -5 M H20~,  10  -4 M NaI, 0.14 M 
NaCl, and 25-30 mU EPO or MPO 
$ Mean ±  SE of four experiments 
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TABLE  IV 
Comparzson of Hzstamme Release by EPO and MCG/EPO Systems* 
Peroxldase 
acuwty 
Histamine release 
EPO  MCG/EPO 
mU  % 
25  151-t-  19(5)~  197+  16(5)  <0.02 
50  209±  14(8)  276±  18(8)  <0.002 
125  346+30(5)  395+44(8) 
* The reacuon mixture was as described for the mast cells plus EPO plus HzO2 
plus iodide system in Table I except that the peroxldase  activity of the EPO 
and MCG/EPO complexes were varied as indicated  Probablhty values for 
the difference  between the EPO and MCIG/EPO systems as determined by 
paired analysis are shown where sigmficant (P <  0.05) 
:~ Mean +  SE of (n) experiments 
with  intact  mast  cells, the complexes bound  to  the cell surface  (Fig.  3).  The  isolated 
granules  appeared  to  break  up  into  smaller  units  each  with  a  dense  core  and  less 
dense  periphery.  Adherence  of the  peroxidase-positive  granule  segments  to  the  cell 
surface and  to the tips of the cytoplasmic protrusions  were seen. 
Cytolys:s.  The  EPO-H20~-halide  system  was cytotoxic to mast  cells when  the EPO 
concentration  was raised to relatively high levels. As shown  in Fig. 4, when  the EPO 
level was  increased  to  100  mU,  combination  with  H202  (2  X  10 -s  M)  and  iodide 
(10 -4 M) resulted in the release of both histamine (68.9%)  and the cytoplasmic marker 
LDH  (59.0%)  from the mast  cells. Omission  of EPO,  H~O2,  or iodide abolished  this 
cytotoxic effect. 
The  cytotoxic  activity  of the  EPO-H202-halide  system  at  high  EPO  levels  was 
confirmed  by  ultastructural  studies  (Fig.  5).  Greater  than  90%  of the  cells  showed 
nonselective loss of cytoplasmic constituents,  mitochondrial  swelling,  and  disruption 
of nuclear  and  cytoplasmic  membranes.  Some  granules  were  released  with  intact 
perigranular  membranes  and  retained  their  electron  density  Other  extracellular 
granules  were membrane-free  and  swollen, similar  to  normally  secreted  granules.  A 
prominent  ring of electron-dense peroxidase-positlve material was seen on the surface Fie  3  Mast celt incubated with MCG/EPO complexes in Tyrode's buffer at 37°C for  ! mm (A, 
X  15,000)  or 5  mm  (B,  ×  47,200)  The cells were examined cytochemlcally for  peroxldase  The 
heterogeneity m  size of the DAB-positive complexes and thew binding to the cell surface and the 
tips of the  mlcrortdges (arrows)  are shown  There  is no  e',ldence of degranulatlon as  would  be 
expected from the absence of H202 and iodide from the reaction mixture 
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FIG  4  Histamine  and LDH release as a funct}on of EPO concentration The reaction mixture 
was as described for the mast cells plus EPO plus H20~ plus iodide system in Table I except that the 
EPO concentratton was varied as indicated  The data represent histamine (0) and LDH (O) release 
above background (htstamine release 8.4 3= 2.5%; LDH release 4 3 3=  1 9%) and are the mean 3= SE 
of four to six experiments 
of membrane-free extracellular granules as well as on the cell surface by diamino- 
benzidine cytochemistry when  the high  level of EPO  (100  mU)  was  used  (Fig.  5). 
Omission of H202 from the staining procedure abolished the reaction.  Peroxidase- 
positive material could not be detected on the granule surface when less EPO (25-30 
mU) was employed under our experimental conditions. 
The effect of serum albumin on histamine release by the EPO-H202-iodide system 
at the low (25 mU)  and high  (100 mU)  EPO concentrations is shown  in Table V. 
Albumin  at  1,000  or 2,500 #g/ml  significantly inhibited  histamine  release  by the 
noncytotoxic 25 mU EPO system (each P <  0.001  as compared with complete EPO 
system without albumin), whereas albumin at  10 or  100 #g/ml did not.  Histamine 
release, however, remained significantly greater than  background  (spontaneous re- 
lease)  at  all  the  albumin  concentrations  employed  (Table  V).  The  results  were 
comparable  at  the  higher  EPO  concentrations  (100  mU);  histamine  release  was 
inhibited by albumin at  100,  1,000, and 2,500 #g/ml (P <  0.05, <0.002, and <0.001, 
respectively, as compared with the complete EPO system without albumin), but in 
each  instance  release  remained  significantly  above  background  (Table  V).  LDH 
release, which is high at this level of EPO indicating cytotoxic activity, remained high 
when  albumin  at  10  or  100 #g/ml  was  added.  However, at  the  higher  albumin 
concentrations (1,000 and  2,500 gg/ml)  LDH release was at  the background level. 
Thus, the addition of  protein under these conditions converted this cytotoxic histamine 
release system to a  noncytotoxic secretory one. Normal rat serum had a comparable 
inhibitory effect on histamine release at the same protein concentrations, whereas a 
protein-free uhrafihrate of serum (10%) was without effect (data not shown). 
Discussion 
Specific secretion of MCG components is induced by the peroxidase-H202-halide 
system. EPO (or MPO) at relatively low levels (4-30 mU) when combined with H202 
and a halide increased the release of the granule marker, histamine, without affecting FIc  5  Mast cells were incubated for 5 min at 37°C In 0.5 ml Tyrode's buffer, pH 7 4, contammg 
100 mU EPO,  10  -4 M  Iodide, and 2 ×  10  -s M  H202  The preparations were treated with DAB  In 
(A)  (× 8,000), the cytotox~c changes are readily apparent  aggregation of the nuclear chromatm, 
nuclear and cytoplasmic membrane breakage, loss of cytoplasm and cytoplasmic constJtutents, and 
cell swelling  The cell surface contains electron-dense deposits not seen on cells similarly treated 
except that H~O2 was omitted from the DAB reaction mixture  In (B) (× 15,700)  and (C) (×  16,600), 
swollen and membrane-free extracellular granules with perox~dase-posmve material on their surface 
(arrows) are seen  Other extracellular granules were membrane bound and umformly electron dense 
comparable with normal Intracellular granules (C)  They are presumably released from disrupted 
cells 
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TABLE V 
Effect of Albumm on Htstamme Release by the EPO Systems * 
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Supplements  Histamine release  LDH release 
Mast cells (spontaneous release) 
Mast cells plus EPO (25 mU) plus 
H202 plus iodtde 
Albumin (10 #g/ml) added 
Albumin (100 #g/ml) added 
Albumm (1,000 #g/ml) added 
Albumin (2,500 p.g/m|) added 
Mast  cells plus  EPO  (100 mU) 
plus H202 plus iodtde 
Albumin (10 #g/ml) added 
Albumm (100 #g/ml) added 
Albumin (1,000 #g/ml) added 
Albumin (2,500 #g/ml) added 
% 
8 4 ± 2.3::[:  38±  10 
504±3.7  <0001 
51.2 ± 6.2  <0001 
367±53  <0.002 
210±30  <0.02 
17.2±18  <002 
669±45  <0.001  716±61 
619±3.3  <0.001  776±8.3 
473±58  <0001  583±42 
359±49  <0.002  3.6±2 1 
273±51  <0.02  28:t: 14 
<0 001 
<0 001 
<0 001 
* The reaction mixture was as described for the mast cells plus EPO plus H202 plus iodide system in Table 
I except that the peroxtdase acuvlty of the EPO was vaned, and human serum albumin was added at the 
indicated concentrations  Probability values for the difference from the mast cells alone  (spontaneous 
release) are shown where slgmficant (P < 0 05). 
:[: Mean ± SE of five experiments 
the  release  of  the  cytoplasmic  marker,  LDH.  At  pH  7.4,  iodide  was  active  at 
concentrations  down  to  10 -5  M,  whereas  chloride  at  0.1  M  was  ineffective.  A 
combination of 0.1  M  chloride and  10 -6 M  iodide, however, could  meet  the halide 
requirement. This synergism between iodide and chloride has been previously reported 
with other target cells (29, 41).  Histamine release with chloride as the sole available 
halide was observed when the pH was lowered to 6.5 or 6.0. 
Degranulation of mast cells without cytolytic activity was confirmed by ultrastruc- 
tural studies.  Degranulation,  with secretion of granule-associated mediators such  as 
histamine, is characterized by a  change in granule morphology with swelling and loss 
of electron  density.  Vacuoles  which  form  around  individual granules  fuse  to  form 
larger vacuoles and channels which open to the outside of the cell where morpholog- 
ically altered granules are detected. These changes have been described for mast cells 
stimulated to secrete by agents such as antigen specific for cell membrane-bound IgE 
(2), compound 48/80  (9), and polymyxin B  sulfate (11,  12). They also are seen when 
mast cells are exposed to the EPO-HzO2-iodide system at relatively low EPO concen- 
trations  (Fig.  1).  The  cell  membrane  remains  intact, other  intracellular organelles 
appear unaffected, and the cell surface continues to exhibit the numerous membrane 
projections characteristic of normal nonsecreting cells. 
Xanthine oxidase when incubated with hypoxanthine has been reported to induce 
noncytotoxic histamine release from mast cells (14). Histamine release by this oxygen 
radical and H202-generating system was inhibited by catalase but was unaffected by 
either superoxide dismutase or mannitol suggesting a  role for H202.  In  their study, 
concentrations of reagent  H202  equal  to or greater than  5  ×  10 -5 M  were found  to 
induce significant histamine release above background (14). We employed H202 at a 
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with  either  iodide  or  EPO;  the  complete  EPO-H202-halide  system  was  required 
(Table I). 
When the EPO level was increased to 100 mU, combination with H20~ and iodide 
resulted in lysis of mast cells with release of LDH as well as histamine and morpho- 
logical evidence of cell disintegration  In contrast with noncytotoxic secretion, the cell 
membrane was disrupted, and the cellular organelles including cytoplasmic granules 
were seen in the extracellular fluid. Some of the extracellular granules were swollen 
and had a decrease in electron density characteristic of secreted granules; others were 
electron opaque and were similar in appearance to the cytoplasmic granules of intact, 
unstimulated mast cells. The latter were presumably released by cell disruption rather 
than secretion. 
We have recently demonstrated  that  EPO,  which  is  a  strongly positive protein, 
binds to the negatively charged MCG matrix to form a complex (30). The peroxidase 
is  bound  largely to  the  surface of the  granule  and  requires  high  sodium  chloride 
concentrations (0.75 M  or greater) for dissociation. Peroxidases have bactericidal and 
cytotoxic activity when combined with  H202 and  a  halide.  EPO retained its toxic 
activity after binding  to mast  cell granules;  indeed,  the  MCG/EPO  complex had 
significantly greater bactericidal (30) and cytotoxic (W. R. Henderson, E. C. Jong, E. 
Y. Chi, and  S. J.  Klebanoff. Unpublished  data.)  activity than did the granule-free 
EPO  system  when  compared  at  equal  guaiacol  units  of peroxidase  activity.  The 
MCG/EPO complex when combined with H202 and iodide also was more effective 
than  an  equivalent  amount  of free EPO  in  the  stimulation  of mast  cell secretion 
(Table IV). 
When mast cells were exposed to the EPO-H202-iodide system at EPO levels (100 
mU) that mediated cytotoxic release of granules, peroxidase activity was detected on 
the surface of the extruded granules as well as on the cell surface by reaction with 
diaminobenzidine. Peroxidase was not detected at these sites when smaller amounts 
of EPO  (30  mU),  which  induced  noncytotoxic histamine  release, were  used.  The 
concentration of EPO under these conditions presumably was below the threshold 
required for detection by our electron microscope procedure. 
These findings suggest that the following sequence of events may occur at sites of 
inflammation  characterized  by  an  eosinophil  and  mast  cell  response.  Eosinophils 
attracted to the site of inflammation may be activated by reaction with an appropri- 
ately opsonized particle or other stimulus to secrete EPO. A  particle too large to be 
ingested, such as a helminth, would favor extracellular release (19); however, peroxi- 
dase  also  could  be  released  when  cell  lysis  occurs  (42)  or  when  granule  rupture 
precedes  the  completion  of the  act  of engulfment.  H202  generated  by  activated 
eosinophils (or other phagocytes in the region) would be expected (23-25), and the 
peroxidase and H202 may combine with a  halide to initiate mast cell secretion. At 
pH  7.4,  iodide, when combined with chloride at  physiological levels, was  active at 
concentrations down to 10  -n M. This is above the physiological level in extracellular 
fluid; however, under in vivo conditions, a steady-state iodide concentration would be 
expected in which  iodide utilized by the peroxidase system would  be immediately 
replaced by an equivalent amount from the total body pool with the potential for the 
utilization of larger amounts by the peroxidase system. If the pH falls to 6.5 or 6.0, 
chloride at physiological concentrations is effective without  iodide.  A  fall in  pH of 
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soluble proteins would be expected to compete with mast cells for the products of the 
peroxidase system. The outcome of this competition would  depend  on the  relative 
concentrations of the target cells or proteins, their affinity for and proximity to the 
peroxidase system, and the level of activity of that system. The total protein content 
of interstitial  fluid  in  which  mast cells and  eosinophils  interact  is  unknown  but  is 
probably  much  lower  than  the  concentration  found  in  serum  (43).  Under  the 
conditions employed here, albumin at concentrations up to 2,500/zg/ml inhibited but 
did not abolish histamine release. LDH release by the EPO system was abolished by 
albumin  under  conditions  in  which  histamine  release remained  high.  Thus  under 
these conditions, a cytotoxic system was converted to a noncytotoxic secretory system 
by extracellular  protein.  The  mast cell  granules  released  by the  EPO-H~O2-halide 
system  would  be  expected  to  form  a  complex  with  EPO  with  retention,  indeed, 
potentiation  of the  secretory  activity  of the  peroxidase  on  mast  cells.  Mast  cell 
secretion may be influenced by neutrophils and MPO in a  similar fashion although 
MPO  does  not  bind  as  firmly  to  MCG  as  does  EPO  (30).  Release  of chemical 
mediators  of immediate  hypersensitivity  and  the  formation  of stable  MCG/EPO 
complexes with augmented bactericidal and cytotoxic activity would be expected to 
influence the subsequent inflammatory response. 
Summary 
Eosinophil  peroxidase  (EPO)  at  relatively  low  levels  (4-30  mU),  when  supple- 
mented with H202 and a halide, induced mast cell degranulation.  Histamine release 
occurred without concomitant release of the cytoplasmic marker lactic dehydrogenase 
(LDH), and this, together with uhrastructural studies, indicated a noncytotoxic effect 
comparable with that  induced  by other mast cell  secretagogues.  At  pH  7.4,  iodide 
was effective at  concentrations  down  to  10  -5  M,  and  although  chloride  alone was 
ineffective at 0.1  M, a combination of 0.1  M  chloride and  10  -~ iodide could meet the 
halide  requirement.  Chloride  alone was effective at  pH 6.5  and 6.0.  EPO could  be 
replaced by myeloperoxidase. 
When the EPO level was increased to 100 mU, combination with H20~- and iodide- 
induced  cytotoxic histamine  release as indicated  by concomitant  LDH release and 
ultrastructural  evidence  of cell  disruption.  This  cytotoxic  response  reverted  to  a 
secretory one on the addition of albumin. Peroxidase was detected on the surface of 
extruded granules by diaminobenzidine cytochemistry. The mast cell granule (MCG)/ 
EPO complex when supplemented with H~O2 and iodide was more effective than free 
EPO in the stimulation of mast cell secretion. The stimulation of mast cell mediator 
release by the EPO-H202-halide system and the formation of MCG/EPO  complexes 
with augmented cytotoxic activity may influence the adjacent inflammatory response. 
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